DEF: Finnovate Acquisition Corp. Seeks Shareholder Approval for Extension to Complete Business Combination with Scage Future

Sentiment:

Proxy Statement


Finnovate Acquisition Corp. is seeking shareholder approval to extend the deadline for completing its business combination with Scage Future by six months, until November 8, 2025, to avoid liquidation.

Summary

  • Finnovate Acquisition Corp. is holding an extraordinary general meeting on May 6, 2025, to seek shareholder approval for an extension to the period within which it must complete a business combination.
  • The primary purpose of the extension is to provide additional time to finalize the business combination with Scage Future, an exempted company incorporated in the Cayman Islands.
  • Without the extension, Finnovate believes it may not be able to complete the Scage Business Combination by May 8, 2025, and would be forced to liquidate.
  • Shareholders of record as of April 14, 2025, are entitled to vote on the proposals.
  • The board of directors recommends voting in favor of the extension proposal.
  • Shareholders have the right to redeem their Class A ordinary shares for a pro rata portion of the trust account, estimated to be approximately $12.06 per share as of the meeting date, regardless of how they vote on the extension proposal.
  • The meeting will also include a proposal to approve the adjournment of the meeting to a later date or dates, if necessary or desirable, at the determination of the Company's Board.
  • The company intends to use its best efforts to complete the Business Combination on or before May 8, 2025.
  • Finnovate will cancel the Meeting and will not implement the Articles Extension if, on or before May 8, 2025, it is able to complete the Business Combination.

Sentiment

Score: 6

Explanation: The document is neutral in tone, presenting the facts of the proposed extension and the associated risks and benefits. The recommendation to vote for the extension suggests a slightly positive outlook from management.

Positives

  • The extension provides an opportunity for shareholders to participate in the potential investment in the combined company with Scage Future.
  • Shareholders retain the right to redeem their shares if a business combination is approved and completed by the extended deadline.
  • The board believes it is advantageous to have the flexibility to determine whether to liquidate and dissolve the company at an earlier date.

Negatives

  • If the business combination is not completed, the company will liquidate, and the warrants will expire worthless.
  • Redemptions in connection with the extension could significantly reduce the amount in the trust account.
  • The company's securities have been suspended from trading on Nasdaq and will be delisted.
  • The company cannot assure shareholders that they will be able to sell their Public Shares in the open market, even if the market price per share is higher than the redemption price.

Risks

  • The company may not be able to complete the business combination by the extended deadline.
  • Redemptions could leave the company with insufficient cash to consummate a business combination.
  • The price of the company's shares may be volatile.
  • The company's securities have been suspended from trading on Nasdaq and will be delisted.
  • The company may be deemed to be an investment company under the Investment Company Act, which may hinder its ability to complete a business combination.
  • The company may not be able to complete an initial business combination with certain potential target companies if a proposed transaction with the target company may be subject to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or regulations.

Future Outlook

The company intends to complete the Scage Business Combination on or before May 8, 2025, if all conditions are satisfied or waived. If the extension is approved, the company will continue to attempt to consummate the Scage Business Combination until the Articles Extension Date.

Management Comments

  • The Board has determined that it is in the best interests of the Company and its shareholders to extend the date by which the Company has to consummate an initial business combination to the Articles Extension Date in order for our shareholders to have the opportunity to participate in an investment in the combined company.
  • The Board believes that given the Company's expenditure of time, effort and money on the Scage Business Combination, circumstances warrant providing Public Shareholders an opportunity to consider the Scage Business Combination.
  • After careful consideration of all relevant factors, the Board has determined that each of the proposals is advisable and recommends that you vote or give instruction to vote FOR such proposals.

Industry Context

SPACs face increasing pressure to complete business combinations within specified timeframes, and extensions are becoming more common as regulatory hurdles and market volatility impact deal closings.

Comparison to Industry Standards

  • The document does not contain enough information to make a comparison to industry standards.
  • The document does not list any comparable companies or projects.
  • The document does not list any global benchmarks.

Stakeholder Impact

  • Shareholders have the opportunity to participate in the potential investment in the combined company with Scage Future.
  • Shareholders retain the right to redeem their shares if a business combination is approved and completed by the extended deadline.
  • If the business combination is not completed, shareholders may receive approximately $12.06 per share upon the liquidation of the trust account, and the warrants will expire worthless.

Next Steps

  • Shareholders to vote on the Articles Extension Proposal and the Adjournment Proposal at the extraordinary general meeting on May 6, 2025.
  • If the Articles Extension Proposal is approved, the Company will file the Second Amended and Restated Memorandum and Articles of Association with the Cayman Islands Registrar of Companies.
  • The Company will continue to work to consummate the initial business combination with Scage prior to the expiration of the Articles Extension.

Key Dates

DateDescription
March 15, 2021Finnovate Acquisition Corp. was incorporated.
November 8, 2021The Company completed the sale of 15,000,000 units at $10.00 per unit.
November 12, 2021The Company closed on the underwriters full over-allotment exercise, resulting in the sale of an additional 2,250,000 units.
August 21, 2023The Company entered into a Business Combination Agreement with Scage Future.
June 18, 2024The Business Combination Agreement was amended.
October 31, 2024The Business Combination Agreement was amended.
December 27, 2024The Registration Statement on Form F-4 was declared effective by the SEC.
April 2, 2025The Business Combination Agreement was amended.
March 28, 2025An extraordinary general meeting of shareholders was held to approve the Scage Business Combination.
April 14, 2025Record date for the extraordinary general meeting.
April 17, 2025The closing price of the Company's ordinary shares on the OTC Markets was $12.25.
April 21, 2025Date of the proxy statement.
May 2, 2025Deadline to tender shares for redemption.
May 6, 2025Extraordinary general meeting to be held.
May 8, 2025Original deadline to complete a business combination.
November 8, 2025Proposed extended deadline to complete a business combination.

Keywords

business combination, extension, redemption, Scage Future, Finnovate Acquisition Corp., liquidation, shareholders, trust account, proxy statement, articles extension proposal

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.